Authors: Gaye Hafez, Jolanta Malyszko, Aleksandra Golenia, Aleksandra Klimkowicz-Mrowiec, Ana Carina Ferreira, Mustafa Arıcı, Annette Bruchfeld, Dorothea Nitsch, Ziad A Massy, Marion Pépin,
Giovambattista Capasso, Laila-Yasmin Mani, Sophie Liabeuf, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target)
The first review of this series described how CKD could represent a risk factor for adverse drug reactions affecting the central nervous system. This second review will describe some of the most common medications associated with cognitive impairment (in the general population and in CKD) and describe their effects.
View publication here.